Internal Medicine, Pulmonary Disease · Elmhurst, NY
NPI
1750392411
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8812 Queens Blvd Ste 1
Elmhurst, NY, 11373
Phone (718) 280-9680
Groups this clinician bills Medicare through
Medicare paid, 2024
$238K
5,448 services
Medicare patients, 2024
283
Average age 74
Drug cost, 2024
$5.6M
15,353 prescriptions
Company payments, 2025
$3,860
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aslam A Jivani was code 95004 (test - miscellaneous), 1,584 times for 22 patients. In total Aslam A Jivani billed 5,448 services in 63 codes, and Medicare paid $238K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 1,584 | 22 | $3.41 | $5,398 |
| 99214 Office E&M - Established | Office | 510 | 227 | $106.61 | $54K |
| 94060 Pulmonary Function Testing | Office | 508 | 214 | $33.74 | $17K |
| 99213 Office E&M - Established | Office | 254 | 152 | $72.26 | $18K |
| 94729 Pulmonary Function Testing | Office | 253 | 171 | $51.07 | $13K |
| 94726 Pulmonary Function Testing | Office | 253 | 171 | $48.49 | $12K |
| 90480 Vaccine Administration | Office | 196 | 149 | $48.31 | $9,469 |
| 91320 Vaccine Product | Office | 196 | 149 | $140.59 | $28K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 193 | 29 | $53.47 | $10K |
| 36415 Venipuncture Blood Collection | Office | 191 | 115 | $8.65 | $1,652 |
| 94010 Pulmonary Function Testing | Office | 123 | 103 | $21.05 | $2,589 |
| 90653 Vaccine Product | Office | 96 | 96 | $80.97 | $7,773 |
| 93000 Electrocardiogram | Office | 94 | 87 | $10.48 | $985 |
| G0008 Administration of influenza virus vaccine | Office | 90 | 89 | $36.42 | $3,278 |
| 96127 Behavioral Health Services | Office | 82 | 76 | $3.57 | $293 |
By year: 2022 $236K for 5,111 services; 2023 $237K for 5,040 services; 2024 $238K for 5,448 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 191 | 115 | $8.65 | $1,652 |
| 87804 Immunoassay | 26 | 12 | $16.22 | $422 |
| 82962 Clinical Chemistry | 17 | 14 | $3.21 | $54.57 |
| 87811 Immunoassay | 14 | 13 | $40.55 | $568 |
Medicare prescription drug claims, 2024
In 2024, the drug Aslam A Jivani prescribed most often to Medicare patients was Montelukast Sodium, with 1,154 prescriptions and refills. In total Aslam A Jivani wrote 15,353 Medicare prescriptions that cost $5.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 1,154 | 2,815 | 427 | $14K |
| Fluticasone Propionate Generic | 1,020 | 1,789 | 419 | $12K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 945 | 1,040 | 378 | $31K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 724 | 1,241 | 223 | $763K |
| Azelastine Hcl Generic | 517 | 784 | 204 | $13K |
| Atorvastatin Calcium Generic | 457 | 1,218 | 154 | $4,712 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 379 | 655 | 124 | $394K |
| Breo Ellipta Fluticasone/Vilanterol | 284 | 451 | 82 | $171K |
| Amlodipine Besylate Generic | 262 | 730 | 92 | $1,662 |
| Losartan Potassium Generic | 240 | 649 | 85 | $2,261 |
| Rosuvastatin Calcium Generic | 215 | 622 | 74 | $2,751 |
| Omeprazole Generic | 198 | 316 | 81 | $1,586 |
| Diclofenac Sodium Generic | 191 | 226 | 71 | $11K |
| Famotidine Generic | 190 | 420 | 73 | $3,868 |
| Prednisone Generic | 189 | 225 | 102 | $483 |
Brand drugs: 4,452 claims; generic drugs: 10,790 claims; opioid claims: 209.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aslam A Jivani $3,860 ($3,860 in general payments such as food, travel and fees) from 25 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $774.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 26 | $774 |
| GlaxoSmithKline, LLC. GSK | 28 | $615 |
| Genzyme Corporation SNY | 9 | $281 |
| Verona Pharma, Inc. VRNA | 12 | $275 |
| Actelion Pharmaceuticals US, Inc. JNJ | 8 | $274 |
| Regeneron Healthcare Solutions, Inc. REGN | 6 | $210 |
| Insmed, Inc. INSM | 8 | $195 |
| Amgen Inc. AMGN | 9 | $191 |
| Novo Nordisk Inc NVO | 9 | $180 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $121 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.